title: Reversal of morphine with naloxone precipitates haloperidol-induced extrapyramidal side effects.
authors.forename: Shu-Lin
authors.initials: SL
authors.lastname: Guo
authors.forename: Chen-Jung
authors.initials: CJ
authors.lastname: Lin
authors.forename: Hsing-Hao
authors.initials: HH
authors.lastname: Huang
authors.forename: Li-Kuei
authors.initials: LK
authors.lastname: Chen
authors.forename: Wei-Zen
authors.initials: WZ
authors.lastname: Sun
mesh_terms: D000293:Adolescent; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000506:poisoning; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000139:chemically induced*; D004347:Drug Interactions; D005260:Female; D006220:Haloperidol / Q000009:adverse effects*; D006801:Humans; D007278:Injections, Spinal; D009020:Morphine / Q000008:administration & dosage / Q000506:poisoning; D009270:Naloxone / Q000008:administration & dosage / Q000009:adverse effects*; D009292:Narcotic Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D009369:Neoplasms / Q000188:drug therapy
chemical_list: D000701:Analgesics, Opioid; D014150:Antipsychotic Agents; D009292:Narcotic Antagonists; D009270:Naloxone; D009020:Morphine; D006220:Haloperidol